Differential expression of the p27(Kip1) mRNA in IFN-sensitive and resistant cell lines

Biochemical and Biophysical Research Communications

Volumn 245, Issue 3, 1998, Pages 752-756

  Moro, A ^a   Calixto, A ^a   Suarez E ^b   Arana M J ^a   Perea, S E ^a  

^a Ctro Ing Genet y B   (Cuba)

^b NONE

Author keywords

Cell cycle; HPV 16 E7; Interferon 2b; mRNA; NCI H82; p27(Kip1); Resistance; RT PCR; Transfection

Indexed keywords

ALPHA2B INTERFERON; INTERFERON; MESSENGER RNA; PROTEIN INHIBITOR; PROTEIN P27; SYNTHETASE; 2',5' OLIGOADENYLATE SYNTHETASE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; E7 PROTEIN, HUMAN PAPILLOMAVIRUS 6B; MICROTUBULE ASSOCIATED PROTEIN; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL CYCLE; CELL GROWTH; GENE EXPRESSION; GENETIC TRANSFECTION; HOST RESISTANCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CELL DIVISION; CELL LINE; DRUG EFFECT; GENETICS; METABOLISM; PAPILLOMA VIRUS; PHASE CONTRAST MICROSCOPY;

HUMAN PAPILLOMAVIRUS TYPE 16;

2',5'-OLIGOADENYLATE SYNTHETASE; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMANS; INTERFERON ALFA-2B; MICROSCOPY, PHASE-CONTRAST; MICROTUBULE-ASSOCIATED PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0032576887     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.8512     Document Type: Article

References (32)

1. Clemens M. J., McNurlan M. A. Regulation of cell proliferation and differentiation by interferons. Biochem J. 226:1985;345-360.
2. Baron S., Tyring S. K., Fleischmann Jr. W. R., Coppenhaver D. H., Niesel D. W., Klimpel G. R., Stanton G. J., Hughes T. K. The interferons. Mechanisms of action and clinical applications. J. Am. Med. Assoc. 266:1991;1375-1383.
3. Kumar R., Atlas I. Interferon-α induces the expression of retinoblastoma gene product in human Burkitt's lymphoma Daudi cells: Role in growth regulation. Proc. Natl. Acad. Sci. USA. 89:1992;6599-6603.
4. Resnitzky D., Tiefenbrun N., Berissi H., Kimchi A. Interferons and IL 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc. Natl. Acad. Sci. USA. 89:1992;402-406.
5. Niggs E. Cyclin-dependent protein kinases:key regulators of the eukaryotic cell cycle. Bioessays. 17:1995;471-480.
6. El-Deiry W. S., Tokino T., Velcuscu V. E., Levy D. E., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
7. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular anti-mitogenic signals. Cell. 78:1994;59-66.
8. Serrano M., Hannon G. J., Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/Cdk4. Nature. 366:1993;704-707.
9. Hannon G. J., Beach D. p15Ink4b is a potential effector of TGF-β-induced cell cycle arrest. Nature. 371:1994;257-260.
10. Viscomi G. C., Grimaldi M., Palazzini E., Silvestri S. Human Leukocyte Interferon Alpha:Structure, Pharmacology, and Therapeutic Applications. 15:1995;445-478.
11. Cirelli R., Tyring S. K. Interferons in human papillomavirus infection. Antivir. Res. 24:1994;191-204.
12. Arany I., Rady P., Tyring S. K. Interferon treatment enhances the expression of underphosphorylated (biologically active) retinoblastoma protein in human papillomavirus infected cells through the inhibitory TGF β1/IFNβ cytokine pathway. Antivir. Res. 23:1994;131-141.
13. Yamada H., Ochi K., Nakada S., Takahara S., Nemoto T., Sekikawa T., Yamada J. H. Interferon mudulates the messenger RNA of G1-controlling genes to suppress the G1-to-S transition in Daudi cells. Molecular and Cellular Biochemistry. 152:1995;149-158.
14. Shiojiri S., Fukunaga R., Ichii Y., Sokawa Y. Structure and expression of a cloned cDNA for human (2′-5′) oligoadenylate synthetase. J. Biochem. 99:1986;1455-1464.
15. Ercolani L., Florence B., Denaro M., Alexander. Isolation and complete sequence of a functional human glyceraldehyde-3 phosphate dehydrogenase gene. J. Biol. Chem. 263:1988;15335-15341.
16. Seedorf K., Kraemmer G., Dürst M., Suhai S., Roewekamp W. G. Human papillomavirus type 16 DNA sequence. Virology. 145:1985;181-185.
17. Sambrook, J. Fritsch, E. F. Maniatis, T. 1989, Molecular cloning: A laboratory manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
18. Moro A., Hernández P. Bacterial expression and immunological detection of the human papillomavirus type 16 E7 protein. Biochem. Biophys. Res. Commun. 226:1996;895-899.
19. Suárez E., Greiser U., Sánchez B., Fernández L., Lage A., Pérez R., Böhmer F-D. Growth inhibition of human lung adenocarcinoma cells by antibodies against EGF receptor and by ganglioside GM3:involvement of receptor-directed protein tyrosine phosphatase(s). Br. J. Cancer. 75:1997;213-220.
20. Mossman T. Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55.
21. Kip1accumulation during the cell cycle. Science. 271:1996;1861-1864.
22. Pagano M., Tam S. W., Theodoras A. M., Beer-Romero P., Del Sal G., Chau V., Yew P. R., Draetta G. F., Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 269:1995;682-685.
23. Liu M., Lee M. H., Cohen M., Bommakanti M., Freedman L. P. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes & Develop. 10:1996;142-153.
24. Poluha W., Poluha D. K., Chang B., Crosbie N. E., Schonhoff C. M., Kilpatrick D. L., Ross A. H. The ciclin-dependent kinase inhibitor p21Waf1 is required for survival of differentiating neuroblastoma cells. Mol. Cell. Biol. 16:1996;1335-1341.
25. FEBS Letters. 411:1997;1-6.
26. Prestridge D. S. SIGNAL SCAN: A computer program that scans DNA sequences for eukaryotic transcriptional elements. CABIOS. 7:1991;203-206.
27. Taniguchi T., Harada H., Lamphier M. Regulation of the IFN system and cell growth by the IRF transcription factors. J. Cancer Clin. Oncol. 121:1995;516-520.
28. Haque S. J., Williams B. R. G. Identification and characterization of an interferon (IFN)-stimulated response element-IFN-stimulated gene factor 3-independent signaling pathway for IFN-α J. Biol. Chem. 269:1994;19523-19529.
29. Tommasino M., Crawford L. Human Papillomavirus E6 and E7:proteins which deregulate the cell cycle. Bioessays. 17:1995;509-518.
30. Schulze A., Zerfass-Thome K., Berges J., Middendorp S., Jansen-Duerr P., Henglein B. Anchorage-dependent transcription of the cyclin A gene. Mol. Cell Biol. 16:1996;4632-4638.
31. Zerfass-Thome K., Zwerschke W., Mannhardt B., Tindle R., Botz J., Jansen-Dürr P. Oncogene. 13:1996;2323-2330.
32. Perea S. E., López O., von Gabain A., Araña M. J. Human Papillomavirus type-16 (HPV-16) major transforming proteins functionally interact with interferon signaling mechanisms. International J. of Oncology. 11:1997;169-173.